A Randomized, Parallel Group, Open-label, Multi-Center Study to Investigate the Efficacy and Safety of Oral BAY85-3934 and Active Comparator (epoetin alfa/beta) in the Maintenance Treatment of Subjects with Anemia Associated with Chronic Kidney Disease.

Investigator

Mandip Panesar, MD Principal Investigator Winnie Su, MD Sub-Investigator

Contact Information

Email: skbrady@buffalo.du